Cannabigerol (CBG) is often called the “mother cannabinoid” because it serves as a precursor from which other major cannabinoids, including CBD and THC, are formed during the cannabis plant’s growth. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting growing interest in the compound for its potential […]
Tag: antibacterial
Cannabinoids Show Selective Antibacterial Effects Against Persistent Dental Infections (pub. Dec 2025)
Persistent endodontic infections—often associated with failed root canal treatments—are commonly caused by bacteria that survive traditional disinfection methods and develop resistance to standard antimicrobial therapies. In this laboratory study, researchers examined whether cannabinoids, including cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC), could inhibit bacteria frequently found in chronic dental infections. The study focused on Enterococcus […]
Cannabigerol (CBG) Shows Antibacterial Effects Against Tooth-Decay-Causing Bacteria (pub. April 2021)
Dental cavities are primarily caused by Streptococcus mutans, a bacteria that thrives in the mouth and produces acids that damage tooth enamel. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in the cannabis plant—could inhibit the growth and activity of this bacteria. Using laboratory (in vitro) models, scientists evaluated how CBG affected […]